GovWire

Guidance: Nitrosamines impurities in medicines

Medicines Healthcare Products Regulatory Agency

August 24
11:03 2023

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) has assessed the risk of nitrosamine formation or presence during the manufacture of human medicines and has provided guidance for manufacturers to avoid the presence of nitrosamine impurities.

Published 24 August 2023

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: